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Ruthenium red was found to inhibit north-activated myosin Mg'*-ATPase in smooth muscle and to bind to myosin heavy chain, but not to F-actin. 
The inhibition by Ruthenium ,'ed of north-activated Mf-÷-ATPasc was of the competitive type wifla respect o actin (K~ 4.4/aM) and of the 
non-competitive type with respect o ATP (/q~ 6.6/aM). However. Ruthenium red scarcely dissociated the nero-heavy meromyosin complex during 
the ATPase reaction. These results uggest that Rmhenium red interacts directly with the binding site for F-aetin on the myosin heavy chain. This 
site is considered to be necessary not for maintaining the binding affinity of myosin for F-actin, but for activation of the M,f'.ATPase. 
Ruthenium red: Smooth muscle: Myosin ATPase 
1. INTRODUCTION 
The contractile protein myosin is accepted as an es- 
sential energy-transducing enzyme that plays a major 
role in the contraction of smooth muscle, and the regu- 
lation of the actin-myosin interaction and of the ATP- 
use activity is very important for kinetic cellular time- 
tions. This regulation is mediated by myosin via the 
Ca'-+-ealmodulin-dependent myosin light chain phos- 
phorylation [1-3]. 
Ruthenium red, [(N H.0.~Rtt-O-Ru(N H 3).s]Clc,.4H,,O. is
a hexavalent polycationic dye which is known to block 
Ca-'÷-induced Ca ~-÷ release fi'om sarcoplasmic reticulum 
in both skeletal and cardiac muscles [4-6], as well as the 
energy-dependent Ca -'+ uptake into isolated mitochon- 
dria [7-9]. It has also been reported that Ruthenium red 
inhibits the Ca -~* pump of the smooth muscle plasma 
membrane [10]. However, the effects of Ruthenium red 
on the contractile proteins in smooth muscle have not 
been reported. 
In this study, we found that Ruthenium red is a po- 
tent and selective inhibitor of the actin-activated Mg -'+- 
ATPase of smooth muscle myosin, using a reconstituted 
system composed of contractile proteins. The mecha- 
nism of action of Ruthenium red on the actin-activated 
Mg:'-ATPase was also examined. 
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2. MATERIALS AND METHODS 
2.1. Preparation of proteins 
Myosin was purified from chicken gir.zard as described previously 
[11]. The lbllowing proteins were purified by previously described 
methods: myosin light chain kinase from chicken gizzard [12]. tro- 
pomyosin from chicken gizzard [13]. actin from rabbit skeletal muscle 
[14], and ¢almodulin from bovine brain [15]. Thiophosphorylated 
smooth muscle myosin was prepared by the previously described 
method [16.17]. Complete phosphorylation f the 20 kDa myosin light 
chain was confirmed by urea-glycerol gel ¢leetrophoresis a described 
by Petrie and Perry [18]. and the extent of phosphorylation f the 20 
kDa myosin light chain was stable throughout the experiments. Heavy 
meromyosin (HM M 1 was prepared by proteolysis with ~-chymotryp- 
sin from thiophosphorylated smooth muscle myosin by the method 
described previously [19]. 
2.2. Assa.v of A TPase activities 
ATPas¢ activities were determined by measuring the amount of P~ 
liberated uring 0--10 min at 25°C by the method escribed previously 
[20]. Each reaction mixture (final volume, 0.2 ml) included 25 mM 
Tris-I-ICl buffer (pl-I 7.5) that contained 80 mM KCI, 5 mM MgCI,. 
I/aM thiophosphorylat~ myosin or HMM. 10/aM F-aetin. in the 
presence or absence of 1.6/aM tropomyosin. 1 mM [y-~-'P]ATP, and 
various amounts of Ruthenium red for assays of'aetin-activatecl Mf*- 
ATPase. For assays of K*.EDTA-ATPase. reaction mixtures included 
25 mM Tris-HCl buffer (pH 7.5) that contained 0.5 M KCI. 2 mM 
EDTA, t /.~M thiophosphorylated myosin or HMM, I mM 
[7-s:PIATP. and Ruthenium red. For assays of K'-EDTA-ATPase. 
reaction mixtures included 25 mM Tris-HCI buffer (pH 7.5) that 
contained 0.5 M KCI, 10 mM CaCi:, 1 .aM thiophosphorylated 
myosin or HMM. 1 mM [y-s:P]ATP, and Ruthenium red. After the 
mixtures had been preincubated in the absence oFATP at 25"C for 5 
rain, the reactions were started by addition of ATP. 
2.3, Bind#~g e.weriments 
The binding of Ruthenium red to smooth muscle actomyosin was 
determined by staining with Ruthenium red after SDS-polyacrylamide 
get eleetrophoresis [21], aceordin 8 to the method escribed previously 
[22]. Gels were stained with 25 mg/I Ruthenium red in 25 mM Tris-HCI 
buffer (pH 7.5) that contained 80 mM KCI, 5 mM MgCi,, and 1 mM 
ATP. 
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2,4. Other techniques attd chemicaL~" 
Protein concentration~ were determined by the method of Bradford 
[23] with bovine serum albumin as the ~tandard. Ruthenium red was 
purch.'tsed fi'om Fluka Chemical Company Ltd. and the concentration 
of Ruthenium red was measured spectrophotometrically t 533 nm by 
the method escribed previously [24]. [y--~-'P]ATP was purchased from 
Amer~ham Corp, ATPyS was purchased from Boehringer Mannheim 
GmbH. a-Chymotrypsin was purchased from Worthington Biochem- 
ical Corp. All other chemicals were of the highest grade commercially 
ovail~ble. 
3. RESULTS AND DISCUSSION 
We examined the effects of Ruthenium red on the 
various types of thiophosphorylated myosin and HMM 
ATPase activities of smooth muscle, namely, those of 
the actin-activated Mg~-*-ATPase, K+-EDTA-ATPase, 
and Ca~-*-ATPase. Fig. 1A shows the dependence on the 
concentration of Ruthenium red of these activities of 
thiophosphorylated myosin. The actin-activated Mg >- 
ATPase activities, both in the presence and in the ab- 
sence of tropomyosin, decreased in a similar fashion 
with increasing concentrations of Ruthenium red, while 
the K*-EDTA-ATPase and the Ca-~*-ATPase activities 
were not significantly inhibited by Ruthenium red. 
Moreover, Ruthenium red did not inhibit the Mg a*- 
ATPase activity of thiophosphorylated myosin alone 
(data not shown). In the case of thiophosphorylated 
HMM, only the actin-activated Mg-'*-ATPase activities, 
measured both in the presence and the absence of tro- 
pomyosin, were inhibited by Ruthenium red, as was 
true in the case of thiophosphorylated myosin (Fig. 1B). 
These results indicate that Ruthenium red is a potent 
and selective inhibitor of the actin-activated Mg-'*-ATP- 
ase of myosin and HMM in smooth muscle. Moreover, 
tlae inhibitory effect of Ruthenium red on the actin- 
activated Mg2+-ATPase was not significantly influenced 
by the presence of tropomyosin. 
To clarify the molecular mechanism of action of Ru- 
thenium red, we examined the ability of Ruthenium red 
to bind to myosin, F-actin, and tropomyosin by the 
staining with Ruthenium red. Fig. 2 shows that Ruthe- 
nium red can bind to the heavy chain region of myosin 
and tropomyosin, but not to F-actin or to myosin light 
chains. These results indicate that Ruthenium red inhib- 
its the actin-activated Mg>-ATPase of myosin via a 
direct effect on myosin heavy chain and not via an effect 
on F-actin. The interaction between Ruthenium red and 
tropomyosin may not be involved in the mechanisms of 
inhibition by Ruthenium red of the actin-activated 
Mg-'÷-ATPase activity, because the presence of tro- 
pomyosin did not influence the inhibitory effect of Ru- 
thenium red. 
The kinetics of the inhibition by Ruthenium red were 
examined with respect to F-actin and ATP for the actin- 
activated Mg>-ATPase of thiophosphorylated smooth 
muscle myosin. The effects of Ruthenium red on the 
actin-activated Mg:+-ATPase with respect o F-actin, in 
the absence of tropomyosin, are shown in Fig. 3A. 
From the double-reciprocal plot, the mode of inhibition 
by Ruthenium red of the actin-activated Mg2+-ATPase 
was found to be of the competitive type with respect o 
F-actin. By contrast, Ruthenium red inhibited the actin- 
activated Mg-'*-ATPase in a non-competitive manner 
with respect o ATP. The values o f&  were 4.4 _ 1.2/.tM 
(n = 3) with respect o F-actin and 6.6 __. 1.3/.tM (n = 
3) with respect o ATP, respectively. These results sug- 
gest that Ruthenium red directly interacts with the actin 
binding site of the myosin heavy chain to accelerate the 
release of P~, but not with the ATP binding or the cata- 
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Fig. 1. Effects o1" Ruthenium red on the ATPa~e activities of smooth muscle thiophosphorylated myosin and HMM. ATPase activities of myosin 
(A) and HM M (B) were measured as descrY, bed in section 2. ill a reconstituted system in the presence of various concentrations of Ruthenium red. 
Actin-actlvated Mga+-ATPase activity, ia tile presence (o). and in the absence (o) of 1.6 ,aM Iropomyosin; Ca:t-ATPase activity. (A); K*-EDTA- 
ATPase acidity, (a), Each point represents the mean of triplicate de/ermlnallons, 
94 
Volume 314, number i FEBS LETTERS Deecnaber 1992 
A B 
kDa 1 2 3 1 2 3 
I~  " - - - - " -  
97.4  - -  
66 .2  
42 .6  - -  ~l l l l~9~lm~ ~1~ .. " - ; " - '~  
: :~ , " . . / . :  
• . . . . . .  
W 
31.0  ~ . . . . , .  • . . . . . .  .. 
. . . .  • ~ ,;/:::.~.?~. 
. . . . , . , . .~ . . ( . .  :, . , . . . : ; : , . . , : !~ . . . ' . f  ,..~1:;.:~.,..'. _ .. • ..;:.-r:.:~ I ,;-!:~:~ 
21.5  ~ qp  ,..-=,, : , , , , :~ : ,~: . .  
. ~ , "  , '- " ; " : ,  , 'b '~  .: • :  " '  
...'7:~:~,.:....:. : ,..: .. :. :? :..~:.?::'1:::~,~,.~,! 
14.4  - -  ~:':: `':~>~ :: : ::::: :":':~ "':"~'~::~ ' 
• : :  ::~;::::~ :~:~' .':~" : ~ :.~'}~:~?!if 
......::-.:/.=.=:.-,,,~..'-,-~:",'.-,.-.f:~,~,,:~. . . . .  ~ ~. ; ,~:~ x;<..~. ,+::~.~;~._,. 
, ~,~ : . ,  , , ,  : ; :7  " . " ' . ' , . '~ ,~/ ,c~ 
Fig. 2. Stainin 8 of smooth muscle myosin, tropomyosin, and actin 
with Ruthenium red. Samples containing approximately equal tool of 
amounts of purified proteins were subjected to electr~phoresis on a 
10% SDS-polyaerylamide g l and then stained with Coomassie blue 
(A) or Ruthenium red (B) as described in section 2. Lane 1, myosin: 
lane 2, tropomyosin; lane 3, aetin. The positions of molecular-weight 
markers (kDa) are as indlcated. The arrowhead indicates the position 
of the myosin heavy chain, and arrows ~how the position of 
tropomyosin. 
lytie site. We also studied the effects of" Ruthenium red 
on the binding of HMM to F-actin by the method de- 
scribed previously [25]. The effects of Ruthenium red on 
the binding ability of HMM for F-aetin were deter- 
mined in parallel with the assay for the actin-activated 
Mg:*-ATPase activity. Ruthenium red scarcely dissoci- 
ated the acto-HMM complex during the ATPase reac- 
A B 
U:3 
/ 
• a,a .o.~ a,o o.~ o.2 o.a a.4 
1/ [F -aet ln l ( / JM  ) 
"~ o,os  I 
.~ U.U4 
~ 0.03' 
Q 
~ o.o2 c , ,  
~ o.oy_ 
-2 -1  0 1 2 3 
1 / [ATP] (m M ) 
Fig. 3. Kinetic analysis of i,hibition of the aetin-aetivated Mg ~- 
ATPase of smooth muscle thiophosphorylated myosin by Ruthenium 
red. The conditions used for the measurements or the actln-activated 
MB-'+-ATPase activity are described in section 2. (A) Double-recipro- 
cal plots of the initial velocity of the ATPase activity vs. the concentra- 
tion of F-actin'. the concentrations of Ruthenium red were 0 ~M (o), 
7.5/~M (o), and 15/.tM (zx), (B) Double-reciprocal plots of the initial 
velocity of the ATPase activity vs. the concentration of ATP; the 
concentrations of Ruthenium red were 0/~M (o), 5pM ()), 10/.~M (a), 
and 15/.tM (A). 
tion (data not shown). These findings indicate that the 
inhibitory effects of Ruthenium red are not due to a 
dissociation of the aeto-HMM complex during the 
ATPase reaction. 
In this study, we found that (i) Ruthenium red can 
bind heavy chain region of the myosin molecule; (ii) 
Ruthenium red inhibits the activation of Mg~*-ATPase 
by F-actin in a competitive fashion with respect o F- 
actin, without affecting the binding affinity of  the aeto- 
HMM complex during the ATPase reaction; and (iii) 
Ruthenium red does not directly affect he catalytic site 
or the ATP-binding site of myosin heavy chain. The 
evidence presented here suggests that the Ruthenium 
red binding site in the heavy chain region of  the myosin 
molecule is necessary for the transient interaction with 
F-actin that is required for activation of myosin MS :+- 
ATPase. Moreover, the site on the myosin heavy chain, 
that is necessary to maintain the affinity for F-actin 
during steady-state ATPase activity appears to be dif- 
ferent from the Ruthenium red-binding site. These re- 
sults are consistent with the previous report hat smooth 
muscle S, heavy chain contains two putative actin-bind- 
ins surface loops, the A I site and the A2 site [26]. More- 
over, in rabbit skeletal S-! it was reported that the S-I 
interacts with actin at two sites, and that the one site 
maintains the acto-S-! link during steady-state ATPase 
activity while the rebinding of  the other site to F-aetin 
is necessary for activation of the ATPase [27]. In addi- 
tion, we speculate that there may be at least wo myosin- 
binding sites on F-actin, because a previous report sug- 
gests that the interface of S-l-actin appears to be com- 
posed of three different contact regions on actin [28]. 
Extensive studies of myosin ATPase in smooth and 
skeletal muscle have been reported and some have in- 
volved the inhibition of the myosin ATPase activity of 
smooth muscle [25,29]. To our knowledge, no drug has 
previously been reported to be a selective inhibitor of 
the actin-activated Mg~+-ATPase activity of smooth 
muscle myosin via a direct effect on the myosin heavy 
chain, in the absence of any effect on the binding affinity 
of myosin for F-actin. Thus, Ruthenium red may be a 
useful chemical tool for studies of the molecular mecha- 
nisms ofactomyosin contractile systems in smooth mus- 
cle. 
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